Cardiovascular Associates of America (CVAUSA), a private equity-backed cardiology management group based out of Florida, has acquired Novolink Health, a care organization that treats high-risk, high-cost patients from the comfort of their own homes. Financial terms of the deal have not been made public.
Novolink, previously known as Duxlink Health, was founded in 2014. The company’s business model involves treating patients with chronic conditions at home so that they are not required to travel each time they have an appointment or require care. According to one study presented virtually at ACC.21, Novolink’s telehospital approach for high-risk patients can reduce the risk of major adverse cardiovascular events by as much as 88% and limit readmissions by 77%.
“Our mission has always been to provide exceptional and personalized care to our patients,” Michael Shen, MD, Novolink Health’s president and chief medical officer, said in a statement. “Joining CVAUSA, one of the largest U.S. cardiology networks, allows us to leverage the extensive resources and reach in our journey to revolutionize healthcare delivery. We are very excited to work closely with Tim and the CVAUSA family to bring our innovative model to more communities and improve the quality of care for all patients in the comfort of their homes.”